ICD-10 category · Morphology of neoplasms · M814-M838

M814 Adenomas and adenocarcinomas

22 codes under M814 in the South African Master Industry Table 2021, 22 valid for clinical use.

Valid: the code is at its most specific level and may go on an account. Heading only: code to a more specific entry beneath it. PMB and CDL: a Prescribed Minimum Benefit or Chronic Disease List condition per the Council for Medical Schemes. † dagger and * asterisk codes are used as a pair. How to read the table
CodeDescriptionUseBenefits
M8140/0Adenoma, NOS, benignValid · not as primary—
M8140/1Bronchial adenoma NOS, uncertain whether benign or malignant (D38.1)Valid · not as primary—
M8140/2Adenocarcinoma in situ, NOSValid · not as primary—
M8140/3Adenocarcinoma, NOS, malignant, primary siteValid · not as primary—
M8140/6Adenocarcinoma, NOS, malignant, metastatic siteValid · not as primary—
M8141/3Scirrhous adenocarcinoma, malignant, primary siteValid · not as primary—
M8141/6Scirrhous adenocarcinoma, malignant, metastatic siteValid · not as primary—
M8142/3Linitis plastica, malignant, primary site (C16.-)Valid · not as primary—
M8142/6Linitis plastica, malignant, metastatic siteValid · not as primary—
M8143/3Superficial spreading adenocarcinoma, malignant, primary siteValid · not as primary—
M8143/6Superficial spreading adenocarcinoma, malignant, metastatic siteValid · not as primary—
M8144/3Adenocarcinoma, intestinal type, malignant, primary site (C16.-)Valid · not as primary—
M8144/6Adenocarcinoma, intestinal type, malignant, metastatic siteValid · not as primary—
M8145/3Carcinoma, diffuse type, malignant, primary site (C16.-)Valid · not as primary—
M8145/6Carcinoma, diffuse type, malignant, metastatic siteValid · not as primary—
M8146/0Monomorphic adenoma, benignValid · not as primary—
M8147/0Basal cell adenoma, benign (D11.-)Valid · not as primary—
M8147/3Basal cell adenocarcinoma, malignant, primary site (C07, C08.-)Valid · not as primary—
M8147/6Basal cell adenocarcinoma, malignant, metastatic siteValid · not as primary—
M8148/0Glandular intraepithelial neoplasia, low grade, benignValid · not as primary—
M8148/2Glandular intraepithelial neoplasia, high grade, in situValid · not as primary—
M8149/0Canalicular adenoma, benignValid · not as primary—

Source and terms

Reproduced from the national table, unaltered.

The Department publishes the table for the industry to load. The ICD-10 Master Industry Table page

Codes and descriptions: ICD-10 Master Industry Table (MIT) 2021, published 16 March 2021 by the National Department of Health, Republic of South Africa. ® National Department of Health: all rights reserved. Reproduced for reference without alteration.

ICD-10 is the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, © World Health Organization. The WHO ICD-10 descriptions appear as published in the MIT.

Prescribed Minimum Benefit (PMB) and Chronic Disease List (CDL) markers: Council for Medical Schemes, PMB Coded List, as read by GreenNotes. Benefit decisions rest with each medical scheme.

Source file: ICD-10_MIT_2021_Excel_16-March_2021.xlsx. Found an error in a code or description? Write to help@greennotes.co.za.

This lookup is a reference to the published code table, not coding advice. Code assignment is the treating practitioner’s responsibility, following the South African ICD-10 Coding Standards and Guidelines and the WHO ICD-10 volumes. GreenNotes does not warrant that the table is complete or current.
This is the South African table. Most ICD-10 results online are the United States’ ICD-10-CM, a different code set that South African medical schemes do not accept. Regulation 5 of the General Regulations under the Medical Schemes Act requires the diagnostic code on every account, and the Master Industry Table is the list it is coded from.

In GreenNotes

Code the consultation once. The invoice and the claim pick it up.

GreenNotes looks codes up from this same table while you write the consultation. The codes you record there, including any the clinical AI included for your review, carry into the invoice and the medical-aid claim.